Innovative
Technologies

At Biogenomics, we harness cutting-edge biotechnology to transform regenerative aesthetics. Our development processes focus on exosome-based therapies and bioactive formulations, ensuring practical applications that empower medical professionals to achieve superior results for their clients.

Practical
Applications

Patented Exosome
Cell Culture Technology

Exosomes are naturally produced in extremely small quantities — only 0.1% during the stem cell culture process. This makes them rare, costly, and difficult to extract. Most companies try to solve this by mass-culturing stem cells multiple times, extracting only exosomes while discarding the rich stem cell culture fluid that contains valuable regenerative factors. 

We took a different approach. 

By optimizing the culture conditions with a specialized dual-functional protein, we increased exosome production by an average of 16 times—all while maintaining their size, function, and bioactivity. Remarkably, these enhanced exosomes show stronger cell binding and deeper tissue penetration, unlocking their full regenerative potential. 

Through our patented cell culture technology, we have transformed human adipose-derived stem cell culture fluid into a potent, stable, and highly bioactive cosmetic ingredient. 

This breakthrough delivers an unprecedented level of highly potent exosomes, paving the way for next-generation regenerative skincare.

Innovative Patents & Publications

Our pioneering work in biotechnology and regenerative aesthetics is backed by an extensive portfolio of patents and peer-reviewed publications. These innovations are setting new industry standards, reinforcing our commitment to scientific excellence and transformative solutions for medical providers.

Want to learn more? Contact us to explore our patented technologies and published studies that are driving the future of regenerative aesthetics.

33
Patents

68
Publications